These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 34013586)

  • 21. Comparison of the Impact of 68Ga-DOTATATE and 18F-FDG PET/CT on Clinical Management in Patients with Neuroendocrine Tumors.
    Panagiotidis E; Alshammari A; Michopoulou S; Skoura E; Naik K; Maragkoudakis E; Mohmaduvesh M; Al-Harbi M; Belda M; Caplin ME; Toumpanakis C; Bomanji J
    J Nucl Med; 2017 Jan; 58(1):91-96. PubMed ID: 27516446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metal Artifact Reduction of CT Scans to Improve PET/CT.
    van der Vos CS; Arens AIJ; Hamill JJ; Hofmann C; Panin VY; Meeuwis APW; Visser EP; de Geus-Oei LF
    J Nucl Med; 2017 Nov; 58(11):1867-1872. PubMed ID: 28490470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced count pediatric whole-body
    Alves VPV; Ata NA; MacLean J; Sharp SE; Li Y; Brady S; Trout AT
    Pediatr Radiol; 2024 Jan; 54(1):170-180. PubMed ID: 37962603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of Penalized-Likelihood Estimation Reconstruction on a Digital Time-of-Flight PET/CT Scanner for
    Lindström E; Sundin A; Trampal C; Lindsjö L; Ilan E; Danfors T; Antoni G; Sörensen J; Lubberink M
    J Nucl Med; 2018 Jul; 59(7):1152-1158. PubMed ID: 29449445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of prone versus supine 18F-FDG-PET of locally advanced breast cancer: Phantom and preliminary clinical studies.
    Williams JM; Rani SD; Li X; Arlinghaus LR; Lee TC; MacDonald LR; Partridge SC; Kang H; Whisenant JG; Abramson RG; Linden HM; Kinahan PE; Yankeelov TE
    Med Phys; 2015 Jul; 42(7):3801-13. PubMed ID: 26133582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Voxel-based comparison of state-of-the-art reconstruction algorithms for 18F-FDG PET brain imaging using simulated and clinical data.
    Vunckx K; Dupont P; Goffin K; Van Paesschen W; Van Laere K; Nuyts J
    Neuroimage; 2014 Nov; 102 Pt 2():875-84. PubMed ID: 25008958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Truncation artifact on PET/CT: impact on measurements of activity concentration and assessment of a correction algorithm.
    Mawlawi O; Erasmus JJ; Pan T; Cody DD; Campbell R; Lonn AH; Kohlmyer S; Macapinlac HA; Podoloff DA
    AJR Am J Roentgenol; 2006 May; 186(5):1458-67. PubMed ID: 16632745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phantom-based acquisition time and image reconstruction parameter optimisation for oncologic FDG PET/CT examinations using a digital system.
    Fragoso Costa P; Jentzen W; Brahmer A; Mavroeidi IA; Zarrad F; Umutlu L; Fendler WP; Rischpler C; Herrmann K; Conti M; Seifert R; Sraieb M; Weber M; Kersting D
    BMC Cancer; 2022 Aug; 22(1):899. PubMed ID: 35978274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of scatter limitation correction: a new method of correcting photopenic artifacts caused by patient motion during whole-body PET/CT imaging.
    Miwa K; Umeda T; Murata T; Wagatsuma K; Miyaji N; Terauchi T; Koizumi M; Sasaki M
    Nucl Med Commun; 2016 Feb; 37(2):147-54. PubMed ID: 26440565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multi-Atlas-Based Attenuation Correction for Brain 18F-FDG PET Imaging Using a Time-of-Flight PET/MR Scanner: Comparison with Clinical Single-Atlas- and CT-Based Attenuation Correction.
    Sekine T; Burgos N; Warnock G; Huellner M; Buck A; Ter Voert EE; Cardoso MJ; Hutton BF; Ourselin S; Veit-Haibach P; Delso G
    J Nucl Med; 2016 Aug; 57(8):1258-64. PubMed ID: 27013697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of (18F)FDG PET/CT and (68Ga)DOTATATE PET/CT imaging methods in terms of detection of histological subtype and related SUVmax values in patients with pulmonary carcinoid tumors.
    Komek H; Can C; Urakçi Z; Kepenek F
    Nucl Med Commun; 2019 May; 40(5):517-524. PubMed ID: 30694875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Shine-through artifact due to high-radioactivity bladder and bowel gas in
    Tomita Y; Ichikawa Y; Sakuma H
    Ann Nucl Med; 2022 Aug; 36(8):736-745. PubMed ID: 35635608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plane-dependent ML scatter scaling: 3D extension of the 2D simulated single scatter (SSS) estimate.
    Rezaei A; Salvo K; Vahle T; Panin V; Casey M; Boada F; Defrise M; Nuyts J
    Phys Med Biol; 2017 Jul; 62(16):6515-6531. PubMed ID: 28737163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Variability and uncertainty of 18F-FDG PET imaging protocols for assessing inflammation in atherosclerosis: suggestions for improvement.
    Huet P; Burg S; Le Guludec D; Hyafil F; Buvat I
    J Nucl Med; 2015 Apr; 56(4):552-9. PubMed ID: 25722452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of a respiratory motion-corrected image reconstruction algorithm in 2-[
    Meng QL; Yang R; Wu RZ; Xu L; Liu H; Yang G; Dong Y; Wang F; Chen Z; Jiang H
    Quant Imaging Med Surg; 2023 Jan; 13(1):370-383. PubMed ID: 36620155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of neuroendocrine liver metastases: a comparison of dynamic contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography.
    Armbruster M; Sourbron S; Haug A; Zech CJ; Ingrisch M; Auernhammer CJ; Nikolaou K; Paprottka PM; Rist C; Reiser MF; Sommer WH
    Invest Radiol; 2014 Jan; 49(1):7-14. PubMed ID: 24002080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Superiority of
    Jha A; Ling A; Millo C; Gupta G; Viana B; Lin FI; Herscovitch P; Adams KT; Taïeb D; Metwalli AR; Linehan WM; Brofferio A; Stratakis CA; Kebebew E; Lodish M; Civelek AC; Pacak K
    Eur J Nucl Med Mol Imaging; 2018 May; 45(5):787-797. PubMed ID: 29204718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improving the detection of small lesions using a state-of-the-art time-of-flight PET/CT system and small-voxel reconstructions.
    Koopman D; van Dalen JA; Lagerweij MC; Arkies H; de Boer J; Oostdijk AH; Slump CH; Jager PL
    J Nucl Med Technol; 2015 Mar; 43(1):21-7. PubMed ID: 25613334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions.
    Eiber M; Takei T; Souvatzoglou M; Mayerhoefer ME; Fürst S; Gaertner FC; Loeffelbein DJ; Rummeny EJ; Ziegler SI; Schwaiger M; Beer AJ
    J Nucl Med; 2014 Feb; 55(2):191-7. PubMed ID: 24309383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of uncertainties in quantitative
    Chen S; Yan D; Qin A; Maniawski P; Krauss DJ; Wilson GD
    Med Phys; 2020 Nov; 47(11):5681-5692. PubMed ID: 32966627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.